Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
Show more...
FAQ
Co-Diagnostics 今天的股價是多少?▼
CODX 目前價格為 $1.21 USD,過去 24 小時上漲了 +5.22%。在圖表上更密切關注 Co-Diagnostics 股價表現。
Co-Diagnostics 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 XNAS 交易所,Co-Diagnostics 的股票以代號 CODX 進行交易。
Co-Diagnostics 的股價在上漲嗎?▼
CODX 股票較上週下跌 -13.57%,本月下跌 -46.93%,過去一年 Co-Diagnostics 下跌 -87.36%。
Co-Diagnostics 的市值是多少?▼
今天 Co-Diagnostics 的市值為 8.45M
Co-Diagnostics 下一次財報日期是什麼時候?▼
Co-Diagnostics 將於 November 05, 2026 公布下一次財報。
Co-Diagnostics 上一季度的財報如何?▼
CODX 上一季度的財報為每股 -1.46 USD,預估為 -3 USD,帶來 +51.33% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Co-Diagnostics 去年的營收是多少?▼
Co-Diagnostics 去年的營收為 622,000USD。
Co-Diagnostics 去年的淨利是多少?▼
CODX 去年的淨收益為 -46.9MUSD。
Co-Diagnostics 有多少名員工?▼
截至 August 22, 2026,公司共有 115 名員工。
Co-Diagnostics 位於哪個產業?▼
Co-Diagnostics從事於Health & Wellness產業。
Co-Diagnostics 何時完成拆股?▼
Co-Diagnostics 上次拆股發生於 January 02, 2026,比例為 1:30。
Co-Diagnostics 的總部在哪裡?▼
Co-Diagnostics 的總部位於 美國 的 SALT LAKE CITY。